Author： Messer W.S. Rajeswaran W.G. Cao Y. Zhang H.-J. El-Assadi A.A. Dockery C. Liske J. O'Brien J. Williams F.E. Huang X.-P. Wroblewski M.E. Nagy P.I. Peseckis S.M.
Publisher： Elsevier
ISSN： 0031-6865
Source： Pharmaceutica Acta Helvetiae, Vol.74, Iss.2, 2000-03, pp. : 135-140
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Muscarinic M1 agonists in the treatment of Alzheimer’s disease
By Korczyn A.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. :
Access to resources
Recommend
By Buzard Daniel J Thatte Jayant Lerner Michael Edwards Jeffrey Jones Robert M
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. :
Muscarinic Receptor Agonists in Alzheimer's Disease: More Than Just Symptomatic Treatment?
By Fisher A.
CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. :